Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Raging Capital Filed 10.6% Activist Stake in $REXI

Raging Capital filed on November 4th for its 10.6% activist stake in Resource America, Inc. (REXI). According to the 13D filing, Raging Capital now has 2.06 million shares in REXI, but the firm’s position in the second quarter is unclear since its 13F filing is not available. Raging Capital made the filing because it delivered a letter to the management of Resource America regarding to the election of the Board of Directors in 2012 annual meeting of stockholders. REXI is now trading at $4.79, representing a loss of 29% in 2011.

Three hedge funds in our tracking list were bullish about the stock in the second quarter. Whitney Tilson’s T2 Partners had 1.08 million shares; David E. Shaw’s D E Shaw had 107 thousand shares; Jim Simons’ Renaissance Technologies had 18 thousand shares.

T2 PARTNERS

Raging Capital Management is a small-to-mid-cap public equity focused hedge fund. The firm was founded by William C. Martin in 2006 in Princeton, NJ. Mr. Martin now serves as the Chairman and Chief Investment Officer in the firm.

Resource America, Inc. is an asset management company. The company operates in Financial Fund Management segment, Real Estate segment, and Equipment Finance segment. The company evaluates, originates, services and manages investment opportunities through its three subsidiaries. The company was founded in 1966 and is based in Philadelphia, Pennsylvania.

Biotech Insider Alert - $5 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!